Deploying Biomolecules as Anti-COVID-19 Agents.
Bat
Corona virus
Disease
Human
Transmission
Journal
Indian journal of microbiology
ISSN: 0046-8991
Titre abrégé: Indian J Microbiol
Pays: India
ID NLM: 0374703
Informations de publication
Date de publication:
Sep 2020
Sep 2020
Historique:
received:
08
05
2020
accepted:
30
05
2020
entrez:
11
7
2020
pubmed:
11
7
2020
medline:
11
7
2020
Statut:
ppublish
Résumé
Severe acute respiratory syndrome coronavirus (SARS-CoV-2) known as COVID-19 has emerged as a major threat to human existence. COVID-19 seems to have undergone adaptive evolution through an intermediate host, most likely bats. The flu leads to severe pneumonia that causes respiratory and multi-organ failure. The absence of any known treatment procedures, drugs, or vaccines has created panic around the World. The need is to develop rapid testing kits, drugs and vaccines. However, these proposals are time-consuming processes. At present social distancing along with previously known traditional medicines can act as quick and short-term alternatives for treating this viral flu.
Identifiants
pubmed: 32647390
doi: 10.1007/s12088-020-00893-4
pii: 893
pmc: PMC7282542
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
263-268Informations de copyright
© Association of Microbiologists of India 2020.
Références
Am J Emerg Med. 2021 Jun;44:220-229
pubmed: 32265065
Int J Biol Sci. 2020 Mar 15;16(10):1708-1717
pubmed: 32226288
Sci Transl Med. 2017 Jun 28;9(396):
pubmed: 28659436
Biotechnol Adv. 2019 Jan - Feb;37(1):68-90
pubmed: 30471318
Int J Surg. 2020 Apr;76:71-76
pubmed: 32112977
mSystems. 2020 Jul 28;5(4):
pubmed: 32723797
J Enzyme Inhib Med Chem. 2020 Dec;35(1):145-151
pubmed: 31724441
Trends Microbiol. 2015 Aug;23(8):468-78
pubmed: 26206723
Biotechnol Adv. 2013 Dec;31(8):1543-61
pubmed: 23954286
Pharmacol Res. 2020 Jul;157:104859
pubmed: 32360480
Biotechnol Adv. 2013 Mar-Apr;31(2):224-45
pubmed: 23142623
J Infect. 2020 Apr;80(4):373-377
pubmed: 32109444
Indian J Microbiol. 2020 Sep;60(3):396-397
pubmed: 32410751
BMC Complement Altern Med. 2017 Feb 24;17(1):130
pubmed: 28235408
Int J Antimicrob Agents. 2020 May;55(5):105938
pubmed: 32171740
J Adv Res. 2020 Mar 16;24:91-98
pubmed: 32257431
Trends Mol Med. 2020 May;26(5):483-495
pubmed: 32359479
J Microbiol Biotechnol. 2020 Apr 28;30(4):571-582
pubmed: 31986566
J Pharm Anal. 2020 Apr;10(2):102-108
pubmed: 32282863
Int J Antimicrob Agents. 2020 Mar;55(3):105924
pubmed: 32081636
Life Sci. 2020 Jun 1;250:117583
pubmed: 32217117
Transfus Med Rev. 2020 Apr;34(2):75-80
pubmed: 32107119
Microb Ecol. 2014 Jul;68(1):13-23
pubmed: 24194099
Phytother Res. 2015 May;29(5):656-61
pubmed: 25586308
Open Microbiol J. 2011;5:1-13
pubmed: 21660112
Crit Rev Microbiol. 2011 May;37(2):121-40
pubmed: 21271798
Int Immunopharmacol. 2020 Jun;83:106455
pubmed: 32272396
Am J Chin Med. 2006;34(1):13-21
pubmed: 16437735
Virus Res. 2020 Jul 15;284:197989
pubmed: 32360300
J Microbiol Immunol Infect. 2020 Jun;53(3):436-443
pubmed: 32307245
J Integr Med. 2020 Mar;18(2):152-158
pubmed: 32113846
Antiviral Res. 2020 Jun;178:104787
pubmed: 32251768
Bioorg Med Chem Lett. 2012 Jun 15;22(12):4049-54
pubmed: 22578462
New Microbes New Infect. 2020 Apr 04;35:100673
pubmed: 32292587
Biomolecules. 2019 Nov 04;9(11):
pubmed: 31690059
Int J Antimicrob Agents. 2020 Jun;55(6):105948
pubmed: 32201353
Indian J Microbiol. 2020 Sep;60(3):398-401
pubmed: 32317810
J Med Virol. 2020 May;92(5):479-490
pubmed: 32052466